Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells - PubMed (original) (raw)
Comparative Study
. 2007 Apr 6;282(14):10660-9.
doi: 10.1074/jbc.M609048200. Epub 2007 Feb 15.
Affiliations
- PMID: 17303569
- DOI: 10.1074/jbc.M609048200
Free article
Comparative Study
Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells
Mariela Garcia Blanes et al. J Biol Chem. 2007.
Free article
Abstract
Vascular endothelial growth factor (VEGF)-stimulated nitric oxide (NO) release from endothelial cells is mediated through the activation of VEGF receptor-2 (VEGFR-2). Herein, we have attempted to determine which autophosphorylated tyrosine residue on the VEGFR-2 is essential for VEGF-mediated endothelial nitric-oxide synthase (eNOS) activation and NO production from endothelial cells. Tyrosine residues 801, 1175, and 1214 of the VEGFR-2 were mutated to phenylalanine, and the mutated receptors were analyzed for their ability to stimulate NO production. We show, both in COS-7 cells cotransfected with the VEGFR-2 mutants and eNOS and in bovine aortic endothelial cells, that the Y801F-VEGFR-2 mutant is unable to stimulate NO synthesis and eNOS activation in contrast to the wild type, Y1175F-VEGFR-2, and Y1214F-VEGFR-2. However, the Y801F mutant retains the capacity to activate phospholipase C-gamma in contrast to the Y1175F-VEGFR-2. Interestingly, the Y801F-VEGFR-2, in contrast to the wild type receptor, does not fully activate phosphatidylinositol 3-kinase or recruit the p85 subunit upon receptor activation. This results in a complete incapacity of the Y801F-VEGFR-2 to stimulate Akt activation and eNOS phosphorylation on serine 1179 in endothelial cells. In addition, constitutive activation of Akt or a phosphomimetic mutant of eNOS (S1179D) fully rescues the inability of the Y801F-VEGFR-2 to induce NO release. Finally, we generated an antibody that specifically recognizes the phosphorylated form of tyrosine 801 of the VEGFR-2 and demonstrate that this residue is actively phosphorylated in response to VEGF stimulation of endothelial cells. We thus conclude that autophosphorylation of tyrosine residue 801 of the VEGFR-2 is essential for VEGF-stimulated NO production from endothelial cells, and this is primarily accomplished via the activation of phosphatidylinositol 3-kinase and Akt signaling to eNOS.
Similar articles
- Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells.
Jin ZG, Wong C, Wu J, Berk BC. Jin ZG, et al. J Biol Chem. 2005 Apr 1;280(13):12305-9. doi: 10.1074/jbc.M500294200. Epub 2005 Jan 21. J Biol Chem. 2005. PMID: 15665327 Free PMC article. - Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
Ning WH, Zhao K. Ning WH, et al. Vascul Pharmacol. 2013 Sep-Oct;59(3-4):76-82. doi: 10.1016/j.vph.2013.07.001. Epub 2013 Jul 12. Vascul Pharmacol. 2013. PMID: 23850990 - eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.
Rafikov R, Fonseca FV, Kumar S, Pardo D, Darragh C, Elms S, Fulton D, Black SM. Rafikov R, et al. J Endocrinol. 2011 Sep;210(3):271-84. doi: 10.1530/JOE-11-0083. Epub 2011 Jun 3. J Endocrinol. 2011. PMID: 21642378 Free PMC article. Review. - Vascular cell signaling by membrane estrogen receptors.
Kim KH, Moriarty K, Bender JR. Kim KH, et al. Steroids. 2008 Oct;73(9-10):864-9. doi: 10.1016/j.steroids.2008.01.008. Epub 2008 Jan 18. Steroids. 2008. PMID: 18325557 Free PMC article. Review.
Cited by
- Indolinones and anilinophthalazines differentially target VEGF-A- and basic fibroblast growth factor-mediated responses in primary human endothelial cells.
Latham AM, Bruns AF, Kankanala J, Johnson AP, Fishwick CW, Homer-Vanniasinkam S, Ponnambalam S. Latham AM, et al. Br J Pharmacol. 2012 Jan;165(1):245-59. doi: 10.1111/j.1476-5381.2011.01545.x. Br J Pharmacol. 2012. PMID: 21699503 Free PMC article. - Biochemical Effects of Exercise on a Fasciocutaneous Flap in a Rat Model.
Aksamitiene E, Baker AL, Roy S, Hota S, Zhang LH, Rodin J, Hobelmann K, Hoek JB, Pribitkin EA. Aksamitiene E, et al. JAMA Facial Plast Surg. 2017 Jul 1;19(4):303-310. doi: 10.1001/jamafacial.2016.2162. JAMA Facial Plast Surg. 2017. PMID: 28278315 Free PMC article. - Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview.
Duan L, Xiong X, Hu J, Liu Y, Li J, Wang J. Duan L, et al. Front Pharmacol. 2017 Oct 17;8:702. doi: 10.3389/fphar.2017.00702. eCollection 2017. Front Pharmacol. 2017. PMID: 29089889 Free PMC article. Review. - Vascular endothelial cell morphology and alignment regulate VEGF-induced endothelial nitric oxide synthase activation.
Bhattacharyya A, Barbee KA. Bhattacharyya A, et al. Cytoskeleton (Hoboken). 2024 Sep;81(9-10):473-487. doi: 10.1002/cm.21872. Epub 2024 May 22. Cytoskeleton (Hoboken). 2024. PMID: 38775643 - Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy.
Shaik F, Cuthbert GA, Homer-Vanniasinkam S, Muench SP, Ponnambalam S, Harrison MA. Shaik F, et al. Biomolecules. 2020 Dec 15;10(12):1673. doi: 10.3390/biom10121673. Biomolecules. 2020. PMID: 33333800 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases